Dr. Keith J. Kaplan | July 31, 2017 | Source: Indica Labs Indica Labs announced today that Douglas Bowman has been appointed Vice President, Pharma
Indica Labs Appoints a Vice President, Pharma Services Read More »
ABSTRACT Although availability of automated platforms has proliferated, there is no standard practice for computer-assisted generation of scores for mRNA in situ hybridization (ISH) visualized
Abstract We conducted a first-in-human study of intravenous delivery of a single dose of autologous T cells redirected to the epidermal growth factor receptor variant
Corrales, NM – April 24th 2017 – Indica Labs proudly announces its breakthrough HALO® Deep Learning technology excelled in the CameLyon17 diagnostic image analysis competition.
HALO® Deep Learning Technology Awarded for Automated Breast Cancer Metastasis Staging Read More »
Abstract Autoantigen-specific immunological tolerance represents a central objective for prevention of type 1 diabetes (T1D). Previous studies demonstrated mucosal antigen administration results in expansion of
Abstract Over the past few decades, clinical and preclinical studies have clearly demonstrated the role of mucins in tumor development. It is well established that
Molecular Pathways: Mucins and Drug Delivery in Cancer Read More »
Abstract Inactivating mutations in the insulin receptor results in extreme insulin resistance. The resulting hyperglycemia is very difficult to treat, and patients are at risk
Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice Read More »
Genetic disruption or pharmacologic inhibition of glucagon signaling effectively lowers blood glucose but results in compensatory glucagon hypersecretion involving expansion of pancreatic α-cell mass. Ben-Zvi
The response rate to immune checkpoint inhibitor therapy for non-small-cell lung cancer (NSCLC) is just 20%. To improve this figure, several early phase clinical trials
Neutrophils dominate the immune cell composition in non-small cell lung cancer Read More »
Diet-induced obesity (DIO) resulting from consumption of a high fat diet (HFD) attenuates normal neuronal responses to leptin and may contribute to the metabolic defense
